Search Results - "Mathis, V."

The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin by Mathis, Mitchell V, Muoio, Brendan M, Andreason, Paul, Avila, Amy M, Farchione, Tiffany, Atrakchi, Aisar, Temple, Robert J

“…To summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the…”
Get full text

Gauge-invariant quantum circuits for U (1) and Yang-Mills lattice gauge theories by Mazzola, Giulia, Mathis, Simon V., Mazzola, Guglielmo, Tavernelli, Ivano

“…Quantum computation represents an emerging framework to solve lattice gauge theories (LGTs) with arbitrary gauge groups, a general and long-standing problem in…”
Get full text

Assessment of astigmatism associated with the iris-fixated ARTISAN aphakia implant: Anterior fixation versus posterior fixation, study of postoperative follow-up at one year by Lajoie, J, Glimois, V, Petit, T, Amelie, R, Varenne, F, Fournie, P, Pagot Mathis, V, Malecaze, F, Wargny, M, Gallini, A, Soler, V

“…The goal of our retrospective, single-center study of a case series was to compare the total, corneal, and internal astigmatism, and the visual acuity at one…”
Get more information

Computational tools for assessing forest recovery with GEDI shots and forest change maps by Holcomb, Amelia, Mathis, Simon V., Coomes, David A., Keshav, Srinivasan

“…Tropical secondary forests are ecosystems of critical importance for protecting biodiversity, buffering primary forest loss, and sequestering atmospheric…”
Get full text

Evaluation of the nurse triage at the ophtalmology emergency department of Pierre-Paul-Riquet Hospital by Renouvin-Benat, A, Sabatier, P, Varenne, F, Pagot-Mathis, V, Fournie, P, Malecaze, F, Gallini, A, Soler, V

“…The steady increase in the number of visits to the various emergency services combined with the decrease in medical demographics, make it necessary to optimize…”
Get more information

On synergy between ultrahigh throughput screening and machine learning in biocatalyst engineering by Gantz, Maximilian, Mathis, Simon V, Nintzel, Friederike E H, Lio, Pietro, Hollfelder, Florian

“…Protein design and directed evolution have separately contributed enormously to protein engineering. Without being mutually exclusive, the former relies on…”
Get more information

Follow-up after surgery for hemorrhagic AMD by Garcia, D., Mahieu, L., Soubrane, G., Salmon, L., Renouvin, A., Pagot-Mathis, V., Matonti, F., Soler, V.

“…The long-term functional results of macular hematoma (MH) surgery in exudative AMD are often limited. The goal of this study was to compare visual outcomes of…”
Get full text

Recurrent bilateral anterior uveitis due to Leishmania infantum in a patient with immune deficiency related to HIV infection: a case report and literature review by Perrin-Terrin, A, Auriol, S, Mahieu, L, Debard, A, Eden, A, Cassagne, M, Pagot-Mathis, V, Malecaze, F, Soler, V

“…We report the case of a 56-year-old patient, presenting with bilateral hypertensive anterior uveitis due to Leishmania infantum, in the setting of immune…”
Get more information

Treatment delay in patients with first episode of retinal detachment in the studied eye in Midi-Pyrénées by Tolou, C, Mahieu-Durringer, L, Cassagne, M, Hamid, S, Billette de Villemeur, R, Gualino, V, Susini, A, Pagot Mathis, V, Gallini, A, Soler, V

“…Retinal detachment (RD) is a potentially blinding condition. Delay in management is a major prognostic factor. In our study, we analyzed the treatment delay…”
Get more information

Isolated patchy perivenular whitening: When white edema of the posterior pole may be vascular in origin but not a retinal artery occlusion by Lajoie, J, Renouvin, A, Mahieu, L, Tolou, C, Suarez, C, Ouardani, S, Hamid, S, Cassagne, M, Pagot-Mathis, V, Matonti, F, Soler, V

“…To identify cases of non-ischemic retinal vein occlusion (RVO) presenting as isolated patchy perivenular retinal whitening and to describe diagnostic…”
Get more information

Efficient Trial Design — FDA Approval of Valbenazine for Tardive Dyskinesia by Davis, Michael C, Miller, Brian J, Kalsi, Jasmeet K, Birkner, Thomas, Mathis, Mitchell V

“…In the case of valbenazine, which was recently approved for tardive dyskinesia, a small company pursued thoughtful, efficient trial design and an unusual…”
Get full text

Dynamic phototherapy with silicone oil in treating choroidal subfoveal neovascularization in high myopia by Soler, V, Pagot-Mathis, V, Quintyn, J-C

“…We report a case of a high myopic patient, treated with photodynamic therapy for macular neovascularization in the presence of silicon oil. Four months later,…”
Get more information

Combined cataract and macular disease surgery by Pagot-Mathis, V

“…Cataract is frequently associated with vitreoretinal diseases. Moreover, cataract is one of the most frequent complications of pars plana vitrectomy. In cases…”
Get more information

Multimodal imaging in the diagnosis of acute macular neuroretinopathy by Tolou, C, Mahieu, L, Salmon, L, Hamid, S, Suarez, C, Garcia, D, Pagot-Mathis, V, Gomane, C, Berot, A, Malecaze, F, Soler, V

“…Acute macular neuroretinopathy is a retinal disease, usually presenting with a "normal fundus". Thus, this condition can be mistaken for optic neuropathy…”
Get more information

A Quantitative Justification of Similarity in Placebo Response Between Adults and Adolescents With Acute Exacerbation of Schizophrenia in Clinical Trials by Kalaria, Shamir N., Zhu, Hao, Farchione, Tiffany R., Mathis, Mitchell V., Gopalakrishnan, Mathangi, Uppoor, Ramana, Mehta, Mehul, Younis, Islam

“…Early‐onset schizophrenia, or “adolescent schizophrenia,” has a global incidence ranging up to 4% of all schizophrenia cases. Clinical data from antipsychotic…”
Get full text

US Food and Drug Administration's Approval of Aripiprazole Tablets With Sensor: Our Perspective by Lee, Daniel J, Farchione, Tiffany R, Mathis, Mitchell V, Muniz, Javier, Muoio, Brendan M

Get full text

Intravitreal bevacizumab pretreatment in vitrectomy for severe diabetic retinopathy: a series of six cases by Couzinet, A, Auriol, S, Lequeux, L, Arné, J-L, Pagot-Mathis, V

“…Bevacizumab (Avastin(®), Roche) is a full-length humanized monoclonal antibody applicable to all subtypes of vascular endothelial growth factor (VEGF). The…”
Get more information

Assessment of Similarity in Antipsychotic Exposure‐Response Relationships in Clinical Trials Between Adults and Adolescents With Acute Exacerbation of Schizophrenia by Kalaria, Shamir N., Farchione, Tiffany R., Mathis, Mitchell V., Gopalakrishnan, Mathangi, Younis, Islam, Uppoor, Ramana, Mehta, Mehul, Wang, Yaning, Zhu, Hao

“…Despite agreement that early‐onset schizophrenia is continuous with the adult‐onset form, quantitative relationships between antipsychotic exposure and…”
Get full text

Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases by Douat, J, Auriol, S, Mahieu-Durringer, L, Ancèle, E, Pagot-Mathis, V, Mathis, A

“…Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF). We report the results of bevacizumab…”
Get more information

Sutureless transconjunctival 20-gauge vitrectomy by Dassie-Ajdid, J, Mahieu, L, Mathis, V, Arné, J-L, Auriol, S

“…To evaluate the safety and efficacy of 20-gauge transconjunctival sutureless vitrectomy for a variety of vitreoretinal conditions. This study was a…”
Get more information